1. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States 2016 [updated 7 June 2016, 28 June 2016].
http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf
.
2. Centers for Disease Control and Prevention Division of HIV/AIDS Prevention. Pregnant Women, Infants and Children: Elimination of Mother-to-Child HIV Transmission (EMCT) in the United States: Centers for Disease Control and Prevention; 2017 [updated 22 February 2017, 16 July 2017].
https://www.cdc.gov/hiv/group/gender/pregnantwomen/emct.html
.
3. Sperling R, Shapiro D, Coombs R, Todd J, Herman S, McSherry G, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996;335(22):1621–9.
4. Cooper E, Charurat M, Mofenson L, Hanson I, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484–94.
5. Townsend C, Cortina-Borja M, Peckham C, de Ruiter A, Lyall H, Tookey P. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS. 2008;22(8):973–81.